|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 264.55 EUR | +4.03% |
|
+3.89% | +10.21% |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.58% | +2.91% | +2.53% | -15.88% | -18.34% | +20.06% | -11.03% | +15.44% | +81.20% | 64.39B | ||
| +7.82% | +44.80% | +44.80% | +44.80% | +44.80% | +44.80% | +44.80% | +44.80% | - | 40.54B | ||
| +0.45% | -0.80% | +18.24% | -19.41% | -33.17% | -50.76% | -58.54% | -59.99% | +6.89% | 37.98B | ||
| -0.02% | +7.82% | +9.86% | +14.80% | +22.35% | +71.45% | -23.68% | -37.72% | -9.87% | 31.89B | ||
| +2.72% | +16.51% | +46.52% | +43.37% | +134.47% | +150.62% | -43.37% | -70.51% | - | 26.69B | ||
| +0.51% | +10.25% | +18.14% | +26.52% | +15.71% | +67.83% | +84.79% | +34.94% | +45.16% | 22.73B | ||
| +6.52% | +5.12% | +6.95% | -6.37% | +4.98% | +3.49% | +174.61% | -14.20% | - | 16.66B | ||
| -0.77% | +4.00% | +4.61% | +20.59% | +39.00% | +60.51% | +123.05% | +197.01% | +346.96% | 16.6B | ||
| +3.76% | +5.92% | +10.17% | +5.25% | -4.56% | +69.06% | +329.66% | +21.42% | - | 13.76B | ||
| -1.04% | -3.30% | +2.22% | +49.33% | +31.23% | +129.60% | +227.79% | +244.07% | +3,108.57% | 12.44B | ||
| +8.59% | +5.52% | +0.95% | -2.10% | -17.02% | -1.97% | +780.76% | +444.53% | +7,100.00% | 12B | ||
| -3.08% | +2.27% | -0.21% | +4.34% | -3.80% | +4.00% | -35.71% | -31.50% | -27.05% | 11.4B | ||
| +0.90% | +9.64% | +21.85% | +52.49% | +52.73% | +173.93% | +225.54% | +445.57% | - | 10.97B | ||
| -1.38% | -0.29% | -3.02% | +2.02% | -15.89% | -13.04% | -21.91% | -60.33% | -54.26% | 6.34B | ||
| -1.18% | +15.91% | +47.63% | +128.20% | +211.22% | +168.33% | +404.70% | -26.68% | - | 6.22B | ||
| +20.00% | +23.91% | +21.67% | +0.85% | +21.10% | +35.11% | +335.61% | +247.15% | - | 5.46B | ||
| +8.61% | +6.47% | +0.17% | -27.94% | -28.54% | -23.88% | +128.57% | +76.51% | +122.39% | 5.07B | ||
| +3.84% | -4.41% | -17.86% | -31.68% | -39.30% | -55.57% | -59.20% | -79.02% | - | 4.88B | ||
| +7.07% | +1.53% | +8.52% | -6.72% | -15.43% | +7.35% | +55.22% | -49.98% | - | 4.7B | ||
| Average | +3.29% | +5.24% | +12.83% | +14.87% | +21.14% | +45.31% | +140.09% | +70.61% | +1,072.00% | 18.46B | |
| Weighted average by Cap. | +2.23% | +6.00% | +15.96% | +12.25% | +18.08% | +43.83% | +78.36% | +42.87% | +614.76% |
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Sector UCB
Select your edition
All financial news and data tailored to specific country editions
















